Healius - Public Comps and Valuation Multiples

Healius Overview

About Healius

Healius is Australia’s second-largest pathology provider and third-largest diagnostic imaging provider, though the latter business is set to be sold in early 2025. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.

Founded

1994

HQ

Employees

9.0K+

Website

healius.com.au

Sectors

Laboratory Services
Medical Imaging & Diagnostics

Financials

LTM Revenue $893M

LTM EBITDA $164M

EV

$927M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Healius Financials

As of September 2025, Healius reported last 12-month revenue of $893M and EBITDA of $164M.

In the same period, Healius generated $751M in LTM gross profit and -$9.3M in net income.

See Healius valuation multiples based on analyst estimates

Healius P&L

In the most recent fiscal year, Healius reported revenue of $882M and EBITDA of -$224M.

Healius expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Healius valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$893M	XXX	$882M	XXX	XXX	XXX
Gross Profit	$751M	XXX	$741M	XXX	XXX	XXX
Gross Margin	84%	XXX	84%	XXX	XXX	XXX
EBITDA	$164M	XXX	-$224M	XXX	XXX	XXX
EBITDA Margin	18%	XXX	-25%	XXX	XXX	XXX
EBIT	$16.4M	XXX	$0.1M	XXX	XXX	XXX
EBIT Margin	2%	XXX	0%	XXX	XXX	XXX
Net Profit	-$9.3M	XXX	-$99.2M	XXX	XXX	XXX
Net Margin	-1%	XXX	-11%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Healius including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $893M. EBITDA for the last twelve months was $164M. In the most recent fiscal year, Healius achieved $882M in revenue and -$224M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$893M	Analyst estimates available to subscribers	$882M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$751M	Analyst estimates available to subscribers	$741M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	84.1% gross margin	Analyst estimates available to subscribers	84.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$164M	Analyst estimates available to subscribers	-$224M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	18.3% EBITDA margin	Analyst estimates available to subscribers	-25.4% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$16.4M	Analyst estimates available to subscribers	$0.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	1.8% EBIT margin	Analyst estimates available to subscribers	0.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$9.3M	Analyst estimates available to subscribers	-$99.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-1.0% net profit margin	Analyst estimates available to subscribers	-11.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Healius

This financial data table provides comprehensive performance metrics for Healius, a company based in Australia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Healius generated $893M in revenue over the last twelve months.
The company achieved $164M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $751M.
Net income over the last twelve months reached -$9.3M.

Fiscal Year Performance

In the most recent fiscal year, Healius reported $882M in total revenue.
Fiscal year EBITDA was -$224M.
The company maintained a gross profit margin of 84.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was -25.4%.
Net profit margin reached -11.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Healius. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Healius Stock Performance

Healius has current market cap of AUD 559M (or $367M), and EV of AUD 1.4B (or $927M).

Market Cap Evolution

Healius Stock Data

As of October 14, 2025, Healius's stock price is AUD 1 (or $1).

See Healius trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$927M	$367M	XXX	XXX	XXX	XXX	$-0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Healius Valuation Multiples

Healius's trades at 0.9x EV/Revenue multiple, and -4.2x EV/EBITDA.

See valuation multiples for Healius and 15K+ public comps

Healius Financial Valuation Multiples

As of October 14, 2025, Healius has market cap of $367M and EV of $927M.

Equity research analysts estimate Healius's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Healius has a P/E ratio of -39.3x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$367M	XXX	$367M	XXX	XXX	XXX
EV (current)	$927M	XXX	$927M	XXX	XXX	XXX
EV/Revenue	1.0x	XXX	0.9x	XXX	XXX	XXX
EV/EBITDA	5.7x	XXX	-4.2x	XXX	XXX	XXX
EV/EBIT	56.5x	XXX	43.0x	XXX	XXX	XXX
EV/Gross Profit	1.2x	XXX	n/a	XXX	XXX	XXX
P/E	-39.3x	XXX	-1.4x	XXX	XXX	XXX
EV/FCF	6.7x	XXX	6.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Healius Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Healius Margins & Growth Rates

Healius's last 12 month revenue growth is 4%

Healius's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Healius's rule of 40 is -18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Healius's rule of X is 29% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Healius and other 15K+ public comps

Healius Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	4%	XXX	-4%	XXX	XXX	XXX
EBITDA Margin	18%	XXX	-22%	XXX	XXX	XXX
EBITDA Growth	13%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-18%	XXX	-18%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	29%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	84%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial